1048 related articles for article (PubMed ID: 8098137)
21. Partial lesions of the dopaminergic nigrostriatal system in rat brain: biochemical characterization.
Hefti F; Melamed E; Wurtman RJ
Brain Res; 1980 Aug; 195(1):123-37. PubMed ID: 6105003
[TBL] [Abstract][Full Text] [Related]
22. Biochemical and behavioral effects of serotonin neurotoxins on the nigrostriatal dopamine system: comparison of injection sites.
Giambalvo CT; Snodgrass SR
Brain Res; 1978 Sep; 152(3):555-66. PubMed ID: 308384
[TBL] [Abstract][Full Text] [Related]
23. Long-term high-frequency electro-acupuncture stimulation prevents neuronal degeneration and up-regulates BDNF mRNA in the substantia nigra and ventral tegmental area following medial forebrain bundle axotomy.
Liang XB; Liu XY; Li FQ; Luo Y; Lu J; Zhang WM; Wang XM; Han JS
Brain Res Mol Brain Res; 2002 Dec; 108(1-2):51-9. PubMed ID: 12480178
[TBL] [Abstract][Full Text] [Related]
24. Glial cell line-derived neurotrophic factor improves intrastriatal graft survival of stored dopaminergic cells.
Apostolides C; Sanford E; Hong M; Mendez I
Neuroscience; 1998 Mar; 83(2):363-72. PubMed ID: 9460746
[TBL] [Abstract][Full Text] [Related]
25. Brain-derived neurotrophic factor enhances function rather than survival of intrastriatal dopamine cell-rich grafts.
Sauer H; Fischer W; Nikkhah G; Wiegand SJ; Brundin P; Lindsay RM; Björklund A
Brain Res; 1993 Oct; 626(1-2):37-44. PubMed ID: 8281451
[TBL] [Abstract][Full Text] [Related]
26. Neurotrophin-4/5 selectively protects nigral calbindin-containing neurons in rats with medial forebrain bundle transections.
Alexi T; Hefti F
Neuroscience; 1996 Jun; 72(4):911-21. PubMed ID: 8735219
[TBL] [Abstract][Full Text] [Related]
27. Striatonigral GABA, dynorphin, substance P and neurokinin A modulation of nigrostriatal dopamine release: evidence for direct regulatory mechanisms.
Reid MS; Herrera-Marschitz M; Hökfelt T; Lindefors N; Persson H; Ungerstedt U
Exp Brain Res; 1990; 82(2):293-303. PubMed ID: 1704847
[TBL] [Abstract][Full Text] [Related]
28. Protection and regeneration of nigral dopaminergic neurons by neurturin or GDNF in a partial lesion model of Parkinson's disease after administration into the striatum or the lateral ventricle.
Rosenblad C; Kirik D; Devaux B; Moffat B; Phillips HS; Björklund A
Eur J Neurosci; 1999 May; 11(5):1554-66. PubMed ID: 10215908
[TBL] [Abstract][Full Text] [Related]
29. Dopaminergic microtransplants into the substantia nigra of neonatal rats with bilateral 6-OHDA lesions. I. Evidence for anatomical reconstruction of the nigrostriatal pathway.
Nikkhah G; Cunningham MG; Cenci MA; McKay RD; Björklund A
J Neurosci; 1995 May; 15(5 Pt 1):3548-61. PubMed ID: 7538563
[TBL] [Abstract][Full Text] [Related]
30. Evidence that [3H]dopamine is taken up and released from nondopaminergic nerve terminals in the rat substantia nigra in vitro.
Kelly E; Jenner P; Marsden CD
J Neurochem; 1985 Jul; 45(1):137-44. PubMed ID: 3923157
[TBL] [Abstract][Full Text] [Related]
31. Histological, behavioural and neurochemical evaluation of medial forebrain bundle and striatal 6-OHDA lesions as rat models of Parkinson's disease.
Yuan H; Sarre S; Ebinger G; Michotte Y
J Neurosci Methods; 2005 May; 144(1):35-45. PubMed ID: 15848237
[TBL] [Abstract][Full Text] [Related]
32. Morphological and functional effects of intranigrally administered GDNF in normal rhesus monkeys.
Gash DM; Zhang Z; Cass WA; Ovadia A; Simmerman L; Martin D; Russell D; Collins F; Hoffer BJ; Gerhardt GA
J Comp Neurol; 1995 Dec; 363(3):345-58. PubMed ID: 8847404
[TBL] [Abstract][Full Text] [Related]
33. Intrastriatal dopaminergic grafts restore inhibitory control over striatal cholinergic neurons.
Herman JP; Lupp A; Abrous N; Le Moal M; Hertting G; Jackisch R
Exp Brain Res; 1988; 73(2):236-48. PubMed ID: 3145893
[TBL] [Abstract][Full Text] [Related]
34. Long distance directed axonal growth from human dopaminergic mesencephalic neuroblasts implanted along the nigrostriatal pathway in 6-hydroxydopamine lesioned adult rats.
Wictorin K; Brundin P; Sauer H; Lindvall O; Björklund A
J Comp Neurol; 1992 Sep; 323(4):475-94. PubMed ID: 1358925
[TBL] [Abstract][Full Text] [Related]
35. Striatal GDNF administration increases tyrosine hydroxylase phosphorylation in the rat striatum and substantia nigra.
Salvatore MF; Zhang JL; Large DM; Wilson PE; Gash CR; Thomas TC; Haycock JW; Bing G; Stanford JA; Gash DM; Gerhardt GA
J Neurochem; 2004 Jul; 90(1):245-54. PubMed ID: 15198683
[TBL] [Abstract][Full Text] [Related]
36. Long-term protection of the rat nigrostriatal dopaminergic system by glial cell line-derived neurotrophic factor against 6-hydroxydopamine in vivo.
Sullivan AM; Opacka-Juffry J; Blunt SB
Eur J Neurosci; 1998 Jan; 10(1):57-63. PubMed ID: 9753113
[TBL] [Abstract][Full Text] [Related]
37. Early and widespread normalization of dopamine-neuropeptide Y interactions in the rat striatum after transplantation of fetal mesencephalon cells.
Moukhles H; Nieoullon A; Daszuta A
Neuroscience; 1992; 47(4):781-92. PubMed ID: 1349734
[TBL] [Abstract][Full Text] [Related]
38. Sequential administration of GDNF into the substantia nigra and striatum promotes dopamine neuron survival and axonal sprouting but not striatal reinnervation or functional recovery in the partial 6-OHDA lesion model.
Rosenblad C; Kirik D; Björklund A
Exp Neurol; 2000 Feb; 161(2):503-16. PubMed ID: 10686072
[TBL] [Abstract][Full Text] [Related]
39. Progressive loss of dopaminergic neurons induced by unilateral rotenone infusion into the medial forebrain bundle.
Norazit A; Meedeniya AC; Nguyen MN; Mackay-Sim A
Brain Res; 2010 Nov; 1360():119-29. PubMed ID: 20807515
[TBL] [Abstract][Full Text] [Related]
40. Glial cell line-derived neurotrophic factor prevents death, but not reductions in tyrosine hydroxylase, of injured nigrostriatal neurons in adult rats.
Lu X; Hagg T
J Comp Neurol; 1997 Nov; 388(3):484-94. PubMed ID: 9368855
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
